Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.
Søndergaard L, Kasner SE, Rhodes JF, Andersen G, Iversen HK, Nielsen-Kudsk JE, Settergren M, Sjöstrand C, Roine RO, Hildick-Smith D, Spence JD, Thomassen L; Gore REDUCE Clinical Study Investigators. Søndergaard L, et al. Among authors: rhodes jf. N Engl J Med. 2017 Sep 14;377(11):1033-1042. doi: 10.1056/NEJMoa1707404. N Engl J Med. 2017. PMID: 28902580 Free article. Clinical Trial.
Patent foramen ovale closure with GORE HELEX or CARDIOFORM Septal Occluder vs. antiplatelet therapy for reduction of recurrent stroke or new brain infarct in patients with prior cryptogenic stroke: Design of the randomized Gore REDUCE Clinical Study.
Kasner SE, Thomassen L, Søndergaard L, Rhodes JF, Larsen CC, Jacobson J. Kasner SE, et al. Among authors: rhodes jf. Int J Stroke. 2017 Dec;12(9):998-1004. doi: 10.1177/1747493017701152. Epub 2017 Mar 24. Int J Stroke. 2017. PMID: 29090661 Clinical Trial.
Evaluating the cost-effectiveness of percutaneous closure of a patent foramen ovale versus medical management in patients with a cryptogenic stroke: from the UK payer perspective.
Hildick-Smith D, Turner M, Shaw L, Nakum M, Hartaigh BÓ, Evans RM, Rhodes JF, Sondergaard L, Kasner SE. Hildick-Smith D, et al. Among authors: rhodes jf. J Med Econ. 2019 Feb;22(2):131-139. doi: 10.1080/13696998.2018.1548355. Epub 2018 Nov 29. J Med Econ. 2019. PMID: 30424680 Free article.
Patent Foramen Ovale Closure Decreases the Incidence but Not the Size of New Brain Infarction on Magnetic Resonance Imaging: An Analysis of the REDUCE Trial.
Messé SR, Erus G, Bilello M, Davatzikos C, Andersen G, Iversen HK, Roine RO, Sjöstrand C, Rhodes JF, Søndergaard L, Kasner SE; Gore REDUCE Study Investigators. Messé SR, et al. Among authors: rhodes jf. Stroke. 2021 Nov;52(11):3419-3426. doi: 10.1161/STROKEAHA.121.034451. Epub 2021 Aug 30. Stroke. 2021. PMID: 34455822 Free PMC article. Clinical Trial.
Comparison of Antiplatelet Therapies for Prevention of Patent Foramen Ovale-Associated Stroke.
Kasner SE, Randall B, Andersen G, Iversen HK, Roine RO, Sjostrand C, Rhodes JF, Søndergaard L; Gore REDUCE Study Investigators. Kasner SE, et al. Among authors: rhodes jf. J Stroke Cerebrovasc Dis. 2020 Apr;29(4):104632. doi: 10.1016/j.jstrokecerebrovasdis.2019.104632. Epub 2020 Feb 7. J Stroke Cerebrovasc Dis. 2020. PMID: 32037269 Clinical Trial.
Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke.
Kasner SE, Rhodes JF, Andersen G, Iversen HK, Nielsen-Kudsk JE, Settergren M, Sjöstrand C, Roine RO, Hildick-Smith D, Spence JD, Søndergaard L; Gore REDUCE Clinical Study Investigators. Kasner SE, et al. Among authors: rhodes jf. N Engl J Med. 2021 Mar 11;384(10):970-971. doi: 10.1056/NEJMc2033779. N Engl J Med. 2021. PMID: 33704944 Clinical Trial. No abstract available.
Atrial fibrillation after closure of patent foramen ovale in the REDUCE clinical study.
Andersen A, Matzen KL, Andersen G, Settergren M, Sjostrand C, Iversen HK, Roine RO, Hildick-Smith D, Spence JD, Rhodes JF, Kasner SE, Sondergaard L, Nielsen-Kudsk JE. Andersen A, et al. Among authors: rhodes jf. Catheter Cardiovasc Interv. 2022 Apr;99(5):1551-1557. doi: 10.1002/ccd.30019. Epub 2021 Nov 13. Catheter Cardiovasc Interv. 2022. PMID: 34773685
European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism.
Pristipino C, Sievert H, D'Ascenzo F, Louis Mas J, Meier B, Scacciatella P, Hildick-Smith D, Gaita F, Toni D, Kyrle P, Thomson J, Derumeaux G, Onorato E, Sibbing D, Germonpré P, Berti S, Chessa M, Bedogni F, Dudek D, Hornung M, Zamorano J; Evidence Synthesis Team; Eapci Scientific Documents and Initiatives Committee; International Experts. Pristipino C, et al. Eur Heart J. 2019 Oct 7;40(38):3182-3195. doi: 10.1093/eurheartj/ehy649. Eur Heart J. 2019. PMID: 30358849 Free article. Review.
Characterization of Recurrent Strokes With and Without Patent Foramen Ovale Closure.
Kasner SE, Kase CS, Turan TN, Rowley HA, Andersen G, Iversen HK, Roine RO, Messé SR, Volpi J, Søndergaard L, Rhodes JF, Sjöstrand C; REDUCE Study Investigators. Kasner SE, et al. Among authors: rhodes jf. J Am Coll Cardiol. 2018 Nov 13;72(20):2542-2544. doi: 10.1016/j.jacc.2018.08.2175. J Am Coll Cardiol. 2018. PMID: 30442299 Free article. Clinical Trial. No abstract available.
84 results